EE3 Cost-Utility Analysis of Xelox Plus Bevacizumab Versus Xelox for Metastatic Colorectal Cancer Treatment in Thailand

Autor:	C Wanitphisitphan, C Kositamongkol, K Korphaisarn, C Akewanlop, V Srimuninnimit, P Phisalprapa
Rok vydání:	2022
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 25:S53
ISSN:	1098-3015
DOI:	10.1016/j.jval.2022.09.258
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::33903cc4be6788d76f690a5eb486660c https://doi.org/10.1016/j.jval.2022.09.258 Zobrazit plný text záznamu Full Text from ScienceDirect